⚠️ NOT FOR HUMAN CONSUMPTION – FOR RESEARCH PURPOSES ONLY ⚠️ CJC‑1295 with DAC (Drug Affinity Complex)A long‑acting synthetic analogue of Growth Hormone‑Releasing Hormone (GHRH; also known as GRF 1‑29) modified by a Drug Affinity Complex (DAC) to extend its duration of action. Form: Lyophilized powder Purity: >98% (HPLC) Storage: Store in a cool, dry, and dark place; long‑term storage typically at −20 °C(Sources: Core Peptides product listing, Wikipedia entry on CJC‑1295 DAC) Research Highlights Induces a sustained increase in Growth Hormone (GH) and Insulin‑like Growth Factor 1 (IGF‑1) secretion in research models. In healthy adult human subjects, a single injection has shown GH levels elevated by 2‑ to 10‑fold for 6 days or more, and IGF‑1 levels by 1.5‑ to 3‑fold for approximately 9‑11 days. Multiple doses led to sustained IGF‑1 elevation up to ~28 days. PubMed The DAC component enables the peptide to bind to plasma albumin, which slows its degradation and clearance — dramatically prolonging its half‑life (often reported at about 6‑8 days) compared to unmodified GRF analogs. PubMed+3Core Peptides+3Wikipedia+3 This compound is strictly intended for laboratory research use only.It is not approved for human or veterinary use, not a dietary supplement, and must not be used to diagnose, treat, cure, or prevent any disease or condition. FOR LABORATORY USE ONLY. NOT FOR HUMAN CONSUMPTION.